SEC Filing Summary: Bellevue Life Sciences Acquisition Corp. (BLAC)
Business Context and Reporting Period
This Form 8-K was filed on August 22, 2024, reporting events as of August 20, 2024. The registrant is Bellevue Life Sciences Acquisition Corp., a Special Purpose Acquisition Company (SPAC) incorporated in Delaware. The filing addresses a critical regulatory issue regarding the company's continued listing on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes and Events
- Delisting Notice: On August 20, 2024, the company received a "Second Notice" from Nasdaq stating it failed to regain compliance with the Minimum Public Holders Requirement (300 public holders) by the August 13, 2024 deadline.
- Compliance History: The company initially received a notice of non-compliance on February 15, 2024. A compliance plan was approved on April 17, 2024, granting an extension until August 13, 2024, which the company failed to meet.
- Immediate Consequence: Unless a hearing is requested, the company's securities (Units, Common Stock, Warrants, and Rights) are subject to suspension or delisting from Nasdaq.
Outlook, Management Commentary, and Risks
- Management Action: The company intends to timely request a hearing before a Hearings Panel. This request will automatically stay any suspension or delisting action pending the hearing outcome.
- Forward-Looking Statements: The filing includes standard disclaimers that statements regarding plans to interact with Nasdaq are projections and not guarantees. Actual results may differ due to economic conditions, financing risks, and other factors.
- Risks: The primary risk is the potential delisting of securities, which could impact liquidity and investor value. The company references broader risks detailed in its Form 10-K and prospectus, including merger and acquisition risks.
Investor Verification Checklist
- Verify the status of the hearing request with the Nasdaq Hearings Panel.
- Monitor subsequent filings for the outcome of the hearing and any potential extension periods granted.
- Review the company's current number of public holders to assess the feasibility of regaining compliance.
- Check for any announcements regarding a potential business combination or liquidation, which are common outcomes for SPACs facing delisting.